152 related articles for article (PubMed ID: 18460899)
21. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
[TBL] [Abstract][Full Text] [Related]
22. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
23. Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone.
Messina S; Bitto A; Aguennouz M; Mazzeo A; Migliorato A; Polito F; Irrera N; Altavilla D; Vita GL; Russo M; Naro A; De Pasquale MG; Rizzuto E; Musarò A; Squadrito F; Vita G
Exp Neurol; 2009 Dec; 220(2):349-58. PubMed ID: 19786019
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice.
Tang Y; Reay DP; Salay MN; Mi MY; Clemens PR; Guttridge DC; Robbins PD; Huard J; Wang B
Gene Ther; 2010 Dec; 17(12):1476-83. PubMed ID: 20720575
[TBL] [Abstract][Full Text] [Related]
26. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.
Kumar A; Boriek AM
FASEB J; 2003 Mar; 17(3):386-96. PubMed ID: 12631578
[TBL] [Abstract][Full Text] [Related]
27. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
28. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.
Hindi SM; Sato S; Choi Y; Kumar A
Hum Mol Genet; 2014 Mar; 23(6):1492-505. PubMed ID: 24163132
[TBL] [Abstract][Full Text] [Related]
29. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
[TBL] [Abstract][Full Text] [Related]
30. Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.
Huynh T; Uaesoontrachoon K; Quinn JL; Tatem KS; Heier CR; Van Der Meulen JH; Yu Q; Harris M; Nolan CJ; Haegeman G; Grounds MD; Nagaraju K
J Pathol; 2013 Oct; 231(2):223-35. PubMed ID: 23794417
[TBL] [Abstract][Full Text] [Related]
31. Improvement of endurance of DMD animal model using natural polyphenols.
Sitzia C; Farini A; Colleoni F; Fortunato F; Razini P; Erratico S; Tavelli A; Fabrizi F; Belicchi M; Meregalli M; Comi G; Torrente Y
Biomed Res Int; 2015; 2015():680615. PubMed ID: 25861640
[TBL] [Abstract][Full Text] [Related]
32. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
33. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
34. Long-term dietary quercetin enrichment as a cardioprotective countermeasure in mdx mice.
Ballmann C; Denney T; Beyers RJ; Quindry T; Romero M; Selsby JT; Quindry JC
Exp Physiol; 2017 Jun; 102(6):635-649. PubMed ID: 28192862
[TBL] [Abstract][Full Text] [Related]
35. Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice.
Enwere EK; Boudreault L; Holbrook J; Timusk K; Earl N; LaCasse E; Renaud JM; Korneluk RG
Hum Mol Genet; 2013 Mar; 22(5):867-78. PubMed ID: 23184147
[TBL] [Abstract][Full Text] [Related]
36. Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway.
Sun CC; Li SJ; Yang CL; Xue RL; Xi YY; Wang L; Zhao QL; Li DJ
J Biol Chem; 2015 Jul; 290(29):17784-17795. PubMed ID: 26013831
[TBL] [Abstract][Full Text] [Related]
37. D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.
Reay DP; Bastacky SI; Wack KE; Stolz DB; Robbins PD; Clemens PR
Mol Med; 2015 May; 21(1):442-52. PubMed ID: 26018805
[TBL] [Abstract][Full Text] [Related]
38. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
39. The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
Sali A; Many GM; Gordish-Dressman H; van der Meulen JH; Phadke A; Spurney CF; Cnaan A; Hoffman EP; Nagaraju K
PLoS One; 2013; 8(7):e66617. PubMed ID: 23843959
[TBL] [Abstract][Full Text] [Related]
40. Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.
Yin X; Tang Y; Li J; Dzuricky AT; Pu C; Fu F; Wang B
Muscle Nerve; 2017 Oct; 56(4):759-767. PubMed ID: 27997693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
